FACULTAD DE MEDICINA
Facultad
Hospital General de Granollers
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Hospital General de Granollers (24)
2023
-
Effects of COVID-19 vaccination on disease activity in patients with rheumatoid arthritis and psoriatic arthritis on targeted therapy in the COVIDSER study
RMD open, Vol. 9, Núm. 1
-
The Effectiveness of Guselkumab in Patients With Hidradenitis Suppurativa Under Clinical Practice Conditions: A Spanish Multicentre Retrospective Study
Actas Dermo-Sifiliograficas, Vol. 114, Núm. 9, pp. 755-762
2022
-
Complement component C4 structural variation and quantitative traits contribute to sex-biased vulnerability in systemic sclerosis
npj Genomic Medicine, Vol. 7, Núm. 1
-
Cutaneous reactions after SARS-CoV-2 vaccination: a cross-sectional Spanish nationwide study of 405 cases*
British Journal of Dermatology, Vol. 186, Núm. 1, pp. 142-152
2020
-
A cross-disease meta-GWAS identifies four new susceptibility loci shared between systemic sclerosis and Crohn’s disease
Scientific Reports, Vol. 10, Núm. 1
-
Virological outcome among HIV infected patients transferred from pediatric care to adult units in Madrid, Spain (1997–2017)
Scientific Reports, Vol. 10, Núm. 1
2019
-
Comparison of seven prognostic tools to identify low-risk pulmonary embolism in patients aged <50 years
Scientific Reports, Vol. 9, Núm. 1
-
Multicentric study on total pancreatectomies
Cirugia Espanola, Vol. 97, Núm. 7, pp. 377-384
-
Sociodemographic changes and trends in the rates of new perinatal HIV diagnoses and transmission in Spain from 1997 to 2015
PLoS ONE, Vol. 14, Núm. 10
2018
-
Real world patient-reported outcomes in HIV-infected adults switching to EVIPLERA®, because of a previous intolerance to cART. PRO-STR study
Current HIV Research, Vol. 16, Núm. 6, pp. 425-435
2016
-
LILRA3 deficiency is not involved in the giant cell arteritis and systemic sclerosis predisposition
Clinical and Experimental Rheumatology
2015
-
Confirmation of CCR6 as a risk factor for anti-topoisomerase I antibodies in systemic sclerosis
Clinical and Experimental Rheumatology, Vol. 33, pp. 31-35
-
Outcome of neuropsychiatric symptoms related to an antiretroviral drug following its substitution by nevirapine: The RELAX study
HIV Medicine, Vol. 16, Núm. 10, pp. 628-634
2014
-
A genome-wide association study follow-up suggests a possible role for PPARG in systemic sclerosis susceptibility
Arthritis Research and Therapy, Vol. 16, Núm. 1
-
Causas que justifican el cambio del tratamiento antirretroviral en personas con infección por el VIH en España (años 2010-2011). Estudio SWITCH AUDIT
Revista Espanola de Quimioterapia, Vol. 27, Núm. 2, pp. 93-97
2009
-
Sustained ventricular arrhythmias in unstable angina patients: Results of the ARIAM database
Medical Science Monitor, Vol. 15, Núm. 6
2008
-
Didanosine, lamivudine, and efavirenz versus zidovudine, lamivudine, and efavirenz for the initial treatment of hiv type 1 infection: Final analysis (48 weeks) of a prospective, randomized, noninferiority clinical trial, GESIDA 3903
Clinical Infectious Diseases, Vol. 47, Núm. 8, pp. 1083-1092
2007
-
Estudio nacional de vigilancia de infección nosocomial en unidades de cuidados intensivos. Informe evolutivo de los años 2003-2005
Medicina Intensiva, Vol. 31, Núm. 1, pp. 6-17
-
Lower weight gain with the orally disintegrating olanzapine than with standard tablets in first-episode never treated psychotic patients
Human Psychopharmacology, Vol. 22, Núm. 1, pp. 11-15
2006
-
Bloqueo auriculoventricular en la angina inestable. Resultados del registro ARIAM
Medicina Intensiva, Vol. 30, Núm. 9, pp. 432-439